Fluxomic assay-assisted diagnosis orientation in a cohort of 11 patients with myopathic form of CPT2 deficiency

Archive ouverte

Fontaine, Monique | Kim, Isabelle | Dessein, Anne-Frédérique | Mention-Mulliez, Karine | Dobbelaere, Dries | Douillard, Claire | Sole, Guilhem | Schiff, Manuel | Jaussaud, Roland | Espil-Taris, Caroline | Boutron, Audrey | Wuyts, Wim | Acquaviva, Cécile | Vianey-Saban, Christine | Roland, Dominique | Joncquel-Chevalier Curt, Marie | Vamecq, Joseph

Edité par CCSD ; Elsevier -

International audience. Carnitine palmitoyltransferase type 2 (CPT2) deficiency, a mitochondrial fatty acid oxidation disorder (MFAOD), is a cause of myopathy in its late clinical presentation. As for other MFAODs, its diagnosis may be evocated when blood acylcarnitine profile is abnormal. However, a lack of abnormalities or specificity in this profile is not exclusive of CPT2 deficiency. Our retrospective study reports clinical and biological data in a cohort of 11 patients with circulating acylcamitine profile unconclusive enough for a specific diagnosis orientation. In these patients, CPT2 gene studies was prompted by prior fluxomic explorations of mitochondrial beta-oxidation on intact whole blood cells incubated with pentadeuterated ([16-H-2(3), 15-H-2(2)])-palmitate. Clinical indication for fluxomic explorations was at least one acute rhabdomyolysis episode complicated, in 5 of 11 patients, by acute renal failure. Major trigger of rhabdomyolysis was febrile infection. In all patients, fluxomic data indicated deficient CPT2 function showing normal deuterated palmitoylcarnitine (C16-Cn) formation rates associated with increased ratios between generated C16-Cn and downstream deuterated metabolites (Sigma deuterated C2-Cn to C14-Cn). Subsequent gene studies showed in all patients pathogenic gene variants in either homozygous or compound heterozygous forms. Consistent with literature data, allelic frequency of the c.338C \textgreater T[p.Ser113Leu] mutation amounted to 68.2% in our cohort. Other missense mutations included c.149C \textgreater A[p.Pro50His] (9%), c.200C \textgreater G[p.A1a200Gly] (4.5%) and previously unreported c.1171A \textgreater G[p.ser391Gly] (4.5%) and c.1420G \textgreater C[p.Ala474Pro] (4.5%) mutations. Frameshift c.1666-1667delTT[p.Leu556val*16] mutation (9%) was observed in two patients unknown to be related.

Consulter en ligne

Suggestions

Du même auteur

A novel mutation of the ACADM gene (c.145C>G) associated with the common c.985A>G mutation on the other ACADM allele causes mild MCAD deficiency: a case report.

Archive ouverte | Dessein, Anne-Frédérique | CCSD

International audience. A female patient, with normal familial history, developed at the age of 30 months an episode of diarrhoea, vomiting and lethargy which resolved spontaneously. At the age of 3 years, the patie...

A novel HADHA variant associated with an atypical moderate and late-onset LCHAD deficiency

Archive ouverte | Dessein, Anne-Frédérique | CCSD

International audience

Functional assessment of creatine transporter in control and X-linked SLC6A8-deficient fibroblasts

Archive ouverte | Joncquel-Chevalier Curt, Marie | CCSD

International audience. Creatine transporter is currently the focus of renewed interest with emerging roles in brain neurotransmission and physiology, and the bioenergetics of cancer metastases. We here report on am...

Chargement des enrichissements...